Effect of conservative treatment in aortoiliac occlusive disease

References

• Norgren L, Hiatt WR, Dormandy JA, et al. Intersociety consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45:Suppl 45S: S5–67.
   PubMed Web of Science ®Google Scholar
• Newman AB, Shemanski L, Manolio TA, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol. 1999;19:538–545.
   PubMed Web of Science ®Google Scholar
• Leng GC, Lee AJ, Fowkes FG, et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1996;25:1172–1181.
   PubMed Web of Science ®Google Scholar
• Diehm C, Schuster A, Allenberg JA, et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: a cross-sectional study. Atherosclerosis. 2004;172:95–105.
   PubMed Web of Science ®Google Scholar
• Smith GD, Shipley MJ, Rose G. Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study. Circulation. 1990;82:1925–1931.
   PubMed Web of Science ®Google Scholar
• Kannel WB, Skinner JJ, Jr, Schwartz MJ, et al. Intermittent claudication. Incidence in the Framingham Study. Circulation. 1970;41:87–883.
   Web of Science ®Google Scholar
• Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001;344:1608–1621.
   PubMed Web of Science ®Google Scholar
• Mazari FAK, Gulati S, Rahman MNA, et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Ann Vasc Surg. 2010;24:69–79.
   PubMed Web of Science ®Google Scholar
• Murphy TP, Soares GM, Kim HM, et al. Quality of life and exercise performance after aortoiliac stent placement for claudication. J Vasc Interv Radiol. 2005;16:947–953.
   PubMed Web of Science ®Google Scholar
• Zeller T. Current state of endovascular treatment of femoro-popliteal artery disease. Vasc Med. 2007;12:223–234.
   PubMed Web of Science ®Google Scholar
• Tunis SR, Bass EB, Steinberg EP. The use of angioplasty, bypass surgery, and amputation in the management of peripheral vascular disease. N Engl J Med. 1991;325:556–562.
   PubMed Web of Science ®Google Scholar
• Maurel B, Lancelevee J, Jacobi D, et al. Endovascular treatment of external iliac artery stenoses for claudication with systematic stenting. Ann Vasc Surg. 2009;23:722–728.
   PubMed Web of Science ®Google Scholar
• Goverde PC, Grimme FA, Verbruggen PJ, et al. Covered endovascular reconstruction of aortic bifurcation (CERAB) technique: a new approach in treating extensive aortoiliac occlusive disease. J Cardiovasc Surg. 2013;54:383–387.
   PubMed Web of Science ®Google Scholar
• Grimme FA, Goverde PC, Verbruggen PJ, et al. Editor’s choice – first results of the covered endovascular reconstruction of the aortic bifurcation (CERAB) technique for aortoiliac occlusive disease. Eur J Vasc Endovasc Surg. 2015;50:638–647.
   PubMed Web of Science ®Google Scholar
• Fitz-Henry J. The ASA classification and peri-operative risk. Ann R Coll Surg Engl. 2011;93:185–187.
   PubMed Web of Science ®Google Scholar
• Lane R, Harwood A, Watson L, et al. Exercise for intermittent claudication. Cochrane Database Syst Rev. 2017;12:CD000990.
   PubMedGoogle Scholar
• Stewart K, Hiatt W, Regensteiner J, et al. Exercise training for claudication. N Engl J Med. 2002;347:1941–1951.
   PubMed Web of Science ®Google Scholar
• Serracino-Inglott F, Owen G, Carter A, et al. All patients benefit equally from a supervised exercise program for claudication. Vasc Endovascular Surg. 2007;41:212–216.
   PubMedGoogle Scholar
• Gommans LN, Saarloos R, Scheltinga MR, et al. Editor's choice – the effect of supervision on walking distance in patients with intermittent claudication: a meta-analysis. Eur J Vasc Endovasc Surg. 2014;48:169–184.
   PubMed Web of Science ®Google Scholar
• Gardner AW, Katzel LI, Sorkin JD, et al. Exercise rehabilitation improves functional outcomes and peripheral circulation in patients with intermittent claudication: a randomized controlled trial. J Am Geriatr Soc. 2001;49:755–762.
   PubMed Web of Science ®Google Scholar
• Ekroth R, Dahllof AG, Gundevall B, et al. Physical training of patients with intermittent claudication: indications, methods, and results. Surgery. 1978;84:640–643.
   PubMed Web of Science ®Google Scholar
• Clifford PC, Davies PW, Hayne JA, et al. Intermittent claudication: is a supervised exercise class worth while? Br Med J. 1980;280:1503–1505.
   PubMed Web of Science ®Google Scholar
• Larsen OA, Lassen NA. Effect of daily muscular exercise in patients with intermittent claudication. Lancet. 1966;2:1093–1096.
   PubMed Web of Science ®Google Scholar
• Fokkenrood HJ, Bendermacher BL, Lauret GJ, et al. Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication. Cochrane Database Syst Rev. 2013;8:CD005263.
   Google Scholar
• Murphy TP, Hirsch AT, Ricotta JJ, et al. CLEVER Steering Committee. The claudication: exercise vs. endoluminal revascularization (CLEVER) study: rationale and methods. J Vasc Surg. 2008;47:1356–1363.
   PubMed Web of Science ®Google Scholar
• Murphy TP, Cutlip DE, Regensteiner JG, et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation. 2012;125:130–139.
   PubMed Web of Science ®Google Scholar
• Murphy TP, Reynolds MR, Cohen DJ, et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. J Am Coll Cardiol. 2015;65:999–1009.
   PubMed Web of Science ®Google Scholar
• Murphy TP, Reynolds MR, Cohen DJ, et al. Correlation of patient-reported symptom outcomes and treadmill test outcomes after treatment for aortoiliac claudication. J Vasc Interv Radiol. 2013;24:1427–1436.
   PubMed Web of Science ®Google Scholar
• Greenhalgh RM, Belch JJ, Brown LC, et al. Mimic trial participants. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. Eur J Vasc Endovasc Surg. 2008;36:680–688.
   PubMed Web of Science ®Google Scholar
• Treesak C, Kasemsup V, Treat-Jacobson D, et al. Cost-effectiveness of exercise training to improve claudication symptoms in patients with peripheral arterial disease. Vasc Med. 2004;9:279–285.
   PubMed Web of Science ®Google Scholar
• Spronk S, Bosch JL, den Hoed PT, et al. Cost-effectiveness of endovascular revascularization compared to supervised hospital-based exercise training in patients with intermittent claudication: a randomized controlled trial. J Vasc Surg. 2008;48:1472–1480.
   PubMed Web of Science ®Google Scholar
• Reynolds MR, Apruzzese P, Galper BZ, et al. Cost-effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the claudication: exercise versus endoluminal revascularization (CLEVER) trial. J Am Heart Assoc. 2014;3:e001233.
   PubMed Web of Science ®Google Scholar
• Savage P, Ricci MA, Lynn M, et al. Effects of home versus supervised exercise for patients with intermittent claudication. J Cardiopulm Rehabil. 2001;21:152–157.
   PubMedGoogle Scholar
• Gardner AW, Parker DE, Montgomery PS, et al. Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication. A randomized controlled trial. Circulation. 2011;123:491–498.
   PubMed Web of Science ®Google Scholar
• Bendermacher BL, Kruidenier LM, Nicolaï SP, et al. Supervised exercise therapy for intermittent claudication. Acta Chir Belg. 2007;107:616–622.
   PubMed Web of Science ®Google Scholar
• Zafar AM, Harris TJ, Murphy TP, et al. Patients' perspective about risks and benefits of treatment for peripheral arterial disease. J Vasc Interv Radiol. 2011;22:1657–1661.
   PubMed Web of Science ®Google Scholar